Welcome to our dedicated page for Caci Intl SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The CACI International Inc (NYSE: CACI) SEC filings page brings together the company’s official U.S. Securities and Exchange Commission disclosures, offering investors a structured view of how this national security-focused information solutions and services provider reports material events, financing arrangements, governance actions, and strategic transactions. CACI’s filings appear under its registrant name and document its activities as a public company serving primarily U.S. government agencies and departments.
Through this page, readers can access current and historical Forms 8-K in which CACI reports items such as quarterly and annual financial results, amendments to credit agreements, accounts receivable purchase arrangements, incentive compensation plans, and board and committee matters. Recent 8-K filings, for example, describe a Second Amended and Restated Credit Agreement with specified term loan and revolving credit facilities, amendments to a Master Accounts Receivable Purchase Agreement, and shareholder approval of the CACI International Inc 2025 Incentive Compensation Plan.
Filings also capture strategic transactions and acquisition agreements. An 8-K dated December 22, 2025 outlines a Purchase Agreement and Plan of Merger under which a CACI subsidiary agreed to acquire ARKA Group L.P. for an aggregate cash purchase price, subject to customary conditions and regulatory approvals. Related disclosures include information on planned debt financing commitments and bridge loan facilities associated with that transaction.
Investors can use this page to locate quarterly and annual reports (Forms 10-Q and 10-K when available), which provide more detailed discussions of segment operations, risk factors, and financial statements, as well as proxy materials such as the DEF 14A that describe director elections, advisory votes on executive compensation, and auditor ratification. Stock Titan’s platform adds AI-powered summaries to help explain the key points in lengthy filings, highlight important sections, and make it easier to interpret complex topics like leverage covenants, incentive plans, and acquisition structures.
For users analyzing CACI stock, this SEC filings page serves as a centralized resource for understanding how the company documents its national security-oriented business, capital structure, governance, and material events in its official regulatory reports.
CACI International executive DeEtte Gray, President of US Operations, exercised previously granted equity awards that vested on April 26, 2026. She converted 10,636 restricted stock units into an equal number of CACI common shares and, in a separate step, 4,512 shares were withheld to cover tax obligations at a value of $516.54 per share, rather than sold in the open market. After these transactions, she holds 39,485 CACI common shares directly, reflecting routine compensation-related activity rather than discretionary buying or selling.
CACI International Inc reported Q3 fiscal 2026 revenue of $2.35 billion, up 8.5% from a year earlier, with net income of $130.4 million. Diluted earnings per share rose to $5.88 from $5.00 as operating income increased 16.6% to $228.9 million.
For the first nine months, revenue reached $6.86 billion and net income was $379.1 million. CACI closed the $2.64 billion ARKA Group acquisition, driving goodwill and intangible assets higher and increasing total assets to $11.6 billion.
To finance acquisitions, long‑term debt grew to $5.21 billion, including a new $800 million Term Loan B‑2 and $500 million of additional 2033 notes. Operating cash flow strengthened to $508.4 million, and total backlog rose to $33.4 billion. An earlier $42 million adverse judgment was affirmed on appeal; CACI plans further appellate steps and has not recorded a related liability.
CACI International reported strong fiscal third-quarter 2026 results with revenues of $2.35 billion, up 8.5% year over year, driven largely by 6.8% organic growth. Net income rose to $130.4 million, while diluted EPS increased 17.6% to $5.88. Adjusted net income was $161.1 million and adjusted diluted EPS reached $7.27, both growing in the mid-teens.
EBITDA was $289.7 million with a 12.3% margin, including $17.4 million of ARKA-related transaction expenses. Free cash flow for the quarter was $221.4 million, up 17.8%. Contract awards totaled $2.2 billion, and total backlog grew to $33.4 billion, with funded backlog at $5.0 billion.
CACI completed the all-cash $2.6 billion acquisition of ARKA Group, expanding electro‑optical, hyperspectral and AI-based geospatial capabilities. Reflecting this and stronger organic performance, the company raised its fiscal 2026 revenue guidance to $9.5–$9.6 billion and nudged up its EBITDA margin outlook to 11.8–11.9%, while reaffirming free cash flow guidance of at least $725 million.
DISBROW LISA S reported acquisition or exercise transactions in this Form 4 filing.
CACI International director Lisa S. Disbrow received a grant of 52 shares of CACI common stock on April 16, 2026 as part of her annual retainer for serving as Chair of the Board. This compensation award increased her directly held stake to 2,329 shares.
CACI International director Susan M. Gordon exercised restricted stock units into common shares. On April 14, 2026, she converted 84 Restricted Stock Units into 84 shares of CACI Common Stock, a non-cash derivative exercise.
Following the transaction, she directly held 2,905 shares of CACI Common Stock and 170 Restricted Stock Units. A prior grant on October 17, 2025 awarded 338 RSUs, scheduled to vest in four tranches: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
Director Ryan D. McCarthy of CACI International Inc. exercised 84 Restricted Stock Units on April 14, 2026, converting them into 84 shares of CACI Common Stock at an exercise price of $0.00 per share. After this transaction, he directly owns 2,237 shares of CACI Common Stock and 170 Restricted Stock Units. The exercised RSUs are part of a 338-unit grant awarded on October 17, 2025, scheduled to vest in four installments through October 11, 2026. This filing reflects a routine compensation-related derivative exercise rather than an open-market stock purchase or sale.
CACI International director Scott C. Morrison exercised restricted stock units into common shares as part of a scheduled equity award. On April 14, 2026, 84 RSUs converted into 84 shares of CACI Common Stock at a stated price of $0.00 per share, increasing his direct holdings to 499 shares. A prior grant of 338 RSUs made on October 17, 2025 is scheduled to vest in four tranches: 84 shares on January 14, 2026, 84 shares on April 14, 2026, 85 shares on July 13, 2026, and 85 shares on October 11, 2026.
CACI International director Philip O. Nolan exercised restricted stock units into common shares as part of his equity compensation. On April 14, 2026, 84 RSUs converted into 84 shares of CACI common stock at a stated price of $0.00 per share, a non-cash equity award.
Following the transaction, Nolan directly held 2,237 CACI common shares and 170 restricted stock units. The footnote explains these RSUs come from a grant of 338 RSUs on October 17, 2025, vesting in four scheduled tranches through October 2026, indicating this is a routine, pre-set vesting event rather than an open-market trade.
CACI International director Lisa S. Disbrow exercised 123 Restricted Stock Units into 123 shares of CACI common stock on April 14, 2026. This transaction increased her direct common share holdings to 2,277 shares and left 246 Restricted Stock Units outstanding from a 492-unit grant awarded on October 16, 2025.
CACI International director Debora A. Plunkett exercised 84 Restricted Stock Units into 84 shares of CACI common stock at a stated price of $0.00 per share. The RSUs are part of a 338-unit grant awarded on October 17, 2025 with scheduled vesting dates through October 11, 2026. Following this transaction, she holds 2,512 shares of CACI common stock directly and 170 RSUs that remain unvested from the same grant.